Other Enterobacteriaceae

Similar documents
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Carbapenemase-Producing Enterobacteriaceae (CPE)

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Horizontal vs Vertical Infection Control Strategies

Multi-Drug Resistant Organisms (MDRO)

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

Two (II) Upon signature

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Infection Prevention and Control Policy

APIC CHAPTER PRESENTATION 7/2014

Risk of organism acquisition from prior room occupants: A systematic review and meta analysis

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Public Health Response to Emerging Resistance

Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

Infection Control of Emerging Diseases

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

Is biocide resistance already a clinical problem?

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Antimicrobial Cycling. Donald E Low University of Toronto

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Preventing Clostridium difficile Infection (CDI)

Multi-drug resistant microorganisms

Summary COMITÉ SUR LES INFECTIONS NOSOCOMIALES DU QUÉBEC. February 2018

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Appropriate antimicrobial therapy in HAP: What does this mean?

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

What bugs are keeping YOU up at night?

Screening programmes for Hospital Acquired Infections

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

CONTAGIOUS COMMENTS Department of Epidemiology

Infectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015

The Hospital Environment as a Source of Resistant Gram Negatives

Presented by: Mary McGoldrick, MS, RN, CRNI

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

The importance of infection control in the era of multi drug resistance

Control of Multidrug-resistant Organisms in a Hospital Environment: Multidimensional Approach

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

EDUCATIONAL COMMENTARY THE RISE OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Enterococcal Species

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Version Control Sheet

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Antimicrobial stewardship

Antimicrobial Stewardship in the Hospital Setting

Epidemiology and Economics of Antibiotic Resistance

Chasing Zero Infections Coaching Call Don t Be Resistant: Reducing MRSA and Other Multi-Drug Resistant Organisms May 8, 2018

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Dissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters

Surveillance of Multi-Drug Resistant Organisms

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Infection control: Need for robust guidelines

Overview of Infection Control and Prevention

Summary of the latest data on antibiotic consumption in the European Union

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and

Collecting and Interpreting Stewardship Data: Breakout Session

2015 Antimicrobial Susceptibility Report

Testimony of the Natural Resources Defense Council on Senate Bill 785

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services

Hospital Acquired Infections in the Era of Antimicrobial Resistance

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Antimicrobial Stewardship Strategy: Antibiograms

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 2 Understanding the spread

Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases

Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients

Jump Starting Antimicrobial Stewardship

Antimicrobial resistance at different levels of health-care services in Nepal

Concise Antibiogram Toolkit Background

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

OAHHS Webinar. Christopher D. Pfeiffer, MD, MHS April 30, 2014

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Human health impacts of antibiotic use in animal agriculture

Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

Transcription:

GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 50: Other Enterobacteriaceae Author Kalisvar Marimuthu, MD Chapter Editor Michelle Doll, MD, MPH Topic Outline Topic outline - Key Issues Known Facts Controversial Issues Suggested Practice Suggested Practice in Under-Resourced Settings Summary References Chapter last updated: April, 2018

KEY ISSUE CPEs remain largely nosocomial although community prevalence have been documented. In an endemic situation, ESBLE colonization or infection among hospitalised patients results primarily from the patients preexisting indigenous flora. Hospital transmission of MDREs frequently involves the hands of healthcare workers or contaminated inanimate surfaces. Outbreaks of MDRE have been linked to understaffing, overcrowding and poor hygiene practices in the hospital. Risk factors for acquiring MDRE varies between endemic and outbreak setting. Reported risk factors include severity of illness, mechanical ventilation, antibiotic pressure and presence of indwelling devices. CPE acquisition outside of healthcare institutions has been linked to food products, travel to high risk areas and medical tourism. Patients with CRE bacteremia have mortality as high as 50% Alcohol-based hand rubs are the most efficacious agents for reducing the number of Enterobacteriaceae on the hands of healthcare providers. CONTROVERSIAL ISSUES Risk factors associated with prolonged CRE carriage is not clearly known but may vary in different groups of patients. Criteria that can be used to declare a patient cleared of CRE is unknown. These criteria may vary depending on epidemiology. The impact of antibiotic restriction on the emergence and spread of multiresistant Enterobacteriaceae in the hospital is under investigation. Several studies examined the effect of restricted use of 1

antibiotics particularly third-generation cephalosporins and carbapenems on the prevalence of resistant Enterobacteriaceae offering conflicting results. Cost effectiveness of various laboratory methods used to detect CPE is unknown. Evidence supporting environmental cleaning for control of CRE are limited to observational studies in outbreak settings. Regardless, most experts consider this as a vital step in CRE control. SUGGESTED PRACTICE Prevention of Transmission Strict hand hygiene compliance Surveillance for CRE carriers, if possible genotyping to identify specific carbapenemases Surveillance cultures for early identification and isolation of CRE carriers should be conducted. Risk stratification should be done at institution-level to identify population needing surveillance. Some groups of patients to be considered for surveillance include contacts of CRE colonized/infected patients and patients with history of recent hospitalization in an endemic setting. Surveillance cultures can be done with rectal swabs or stool samples. Regular monitoring for CRE from clinical cultures should be undertaken. Physical separation of CRE carriers Single room isolation is available; or Cohorting of CRE carriers with dedicated nursing, especially in an outbreak situation Contact precautions for CRE carriers 2

Should include: ensuring appropriate patient placement, usage of personal protective equipment including gloves and gown, and use of disposable or dedicated patient-care equipment. Pre-emptive contact precaution can be considered for high risk patients Environmental cleaning Cleaning of the patient zone is important to prevent transmission of CRE. For single rooms, the entire room should be terminally cleaned after discharging a CRE carrier before admitting another patient. Cleaning staff should be adequately trained. Surveillance cultures of the environment may be considered especially in outbreak setting. Antibiotic stewardship program to reduce unnecessary antibiotic utilization Monitoring, audit and feedback SUGGESTED PRACTICE IN UNDER-RESOURCED SETTINGS Adequate staffing to ensure adequate staff-to-patient ratio as poor staffing is associated with transmission of MDRE Ensuring availability of alcohol-based hand rubs Ensuring availability of microbiology laboratory to be able to identify CREs Monitoring of CREs from clinical cultures should be conducted and trend should be monitored to identify outbreaks In settings where single rooms are not available, strict adherence to contact precautions are vital. Within ward cohorting of CRE carriers may be considered e.g. placing CRE patients at the end of the ward 3

SUMMARY The predominant genera of Enterobacteriaceae are Escherichia, Klebsiella, Enterobacter, Citrobacter, Proteus, Serratia, Salmonella and Shigella. Enteric pathogens are not discussed in this chapter. Incidence of CRE is increasing worldwide. Screening of high risk patients to identify CRE carriers early and physical separation while in the hospital are important CRE control strategies. Modification and adaptation of international guidelines are necessary to control CREs in resource limited settings. REFERENCES 1. World Health Organization. "Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities." (2017). 2. Centers for Disease Control and Prevention. "CRE toolkit guidance for control of carbapenem-resistant Enterobacteriaceae (CRE)." Atlanta, GA: CDC (2012). 3. Munoz-Price, L. Silvia, Laurent Poirel, Robert A. Bonomo, Mitchell J. Schwaber, George L. Daikos, Martin Cormican, Giuseppe Cornaglia et al. "Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases." The Lancet infectious diseases 13, no. 9 (2013): 785-796. 4

4. Tacconelli, E., M. A. Cataldo, S. J. Dancer, G. Angelis, M. Falcone, U. Frank, G. Kahlmeter et al. "ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients." Clinical Microbiology and Infection 20, no. s1 (2014): 1-55. 5. Storr, Julie, Anthony Twyman, Walter Zingg, Nizam Damani, Claire Kilpatrick, Jacqui Reilly, Lesley Price et al. "Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations." Antimicrobial Resistance & Infection Control 6, no. 1 (2017): 6. 6. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. Twenty Second Informational Supplement (January 2012), CLSI document M 100- S22. Wayne, Pennsylvania, 2012. 7. Harbarth S, Sudre P, Dharan S, et al. Outbreak of Enterobacter cloacae Related to Understaffing, Overcrowding, and Poor Hygiene Practices. Infect Control Hosp Epidemiol 1999; 20:598 603. 8. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenemresistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010 ;31 :620-626 9. Marchaim D, Chopra T, Bhargava A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae : the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817-830 5

10. Tschudin-Sutter S, Frei R, Dangel M, et al. rate of transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae without contact isolation. Clin Infect Dis 2012;55:1505-1511. 6